首页> 美国卫生研究院文献>BMC Nephrology >HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival

【2h】

HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival

机译：HMG-CoA还原酶抑制剂在接受他克莫司治疗的肾移植受者中：他汀类药物与患者或移植物生存期的改善无关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe beneficial effects of early statin use in kidney transplant recipients, especially those on tacrolimus-based immunosuppression, are not well established. We evaluated the predictors of statin use following kidney transplantation and examined its association with patient and allograft survival.

机译：背景早期他汀类药物在肾移植受者中的有益作用，特别是对基于他克莫司的免疫抑制作用尚不十分清楚。我们评估了他汀类药物在肾脏移植后使用的预测因素，并检查了其与患者和同种异体移植物存活的关系。

著录项

期刊名称 BMC Nephrology
作者
Nizar Younas; Christine M Wu; Ron Shapiro; Jerry McCauley; James Johnston; Henkie Tan; Amit Basu; Heidi Schaefer; Cynthia Smetanka; Wolfgang C Winkelmayer; Mark Unruh;
展开▼
作者单位

展开▼
年(卷),期 2010(11),-1
年度 2010
页码 5
总页数 9
原文格式 PDF
正文语种
中图分类泌尿科学（泌尿生殖系疾病）;小儿泌尿科学;肾疾病;
关键词

相似文献

外文文献
中文文献
专利

1. HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival [J] . Nizar Younas, Christine M Wu, Ron Shapiro, BMC Nephrology . 2010,第1期

机译：HMG-CoA还原酶抑制剂在接受他克莫司治疗的肾移植受者中：他汀类药物与患者或移植物生存期的改善无关
2. Sirolimus Versus Tacrolimus in Kidney Transplant Recipients Receiving Mycophenolate Mofetil and Steroids: Focus on Acute Rejection, Patient and Graft Survival [J] . Yang Aifang, Wang Bin American journal of therapeutics . 2015,第2期

机译：西罗莫司和他克莫司对接受麦考酚酸酯和类固醇的肾移植受者的关系：侧重于急性排斥，患者和移植物的存活
3. Tacrolimus/sirolimus versus tacrolimus/mycophenolate in kidney transplantation: improved 3-year graft and patient survival in recent era. [J] . Gralla J, Wiseman AC Transplantation: Official Journal of the Transplantation Society . 2009,第11期

机译：他克莫司/西罗莫司与他克莫司/麦考酚酯在肾脏移植中的关系：改善了近三年的移植物和患者的存活率。
4. Statin Inhibition of HMG-CoA Reductase by Quantum Biochemistry Computations [C] . Fulco U.L., Albuquerque E.L., da Silva L.R. Southern Biomedical Engineering Conference . 2013

机译：量子生化计算对HMG-CoA还原酶的他汀类抑制剂
5. Survival Benefit of Statins among Prospective Kidney Transplant Recipients [D] . Co, Michael Lawrenz F. 2018

机译：前瞻性肾移植受者中他汀类药物的生存益处
6. Living Donor Kidney Transplantation Improves Graft and Recipient Survival in Patients with Multiple Kidney Transplants [O] . Maria Irene Bellini, Aisling E Courtney, Jennifer A McCaughan 2020

机译：活体供体肾移植改善了多个肾移植患者的移植物和受体存活
7. HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival [O] . Nizar Younas, Christine M Wu, Ron Shapiro, 2010

机译：HMG-CoA还原酶抑制剂在接受他克莫司治疗的肾移植受者中：他汀类药物与患者或移植物生存期的改善无关

HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival

摘要

著录项

相似文献

相关主题

期刊订阅